New Longevity Biotech Fellowship launches

Latest articles

The Alliance for Longevity Initiatives – fighting aging

Advancing legislation and policies that aim to increase healthy human lifespan. Longevity is a journey that would be good to imagine we're all taking together;...

Team builds first living robots – that can reproduce

AI-designed Xenobots reveal entirely new form of biological self-replication which could prove promising for regenerative medicine. Birds do it, bees do it... now even living...

Aging in place trailblazer focus – Carewell

Carewell – aiding individuals through their caregiving journey with empathy and knowledge. Over the coming weeks, we will be bringing you extracts from 7 trailblazer...

Humanpeople raising £700k for AI preventative health platform

Digital preventative health platform combines blood, DNA and microbiome testing to power up your healthspan with highly personalised supplements. DISCLOSURE: Longevity.Technology (a brand of...

Most read

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Editor's picks

The Alliance for Longevity Initiatives – fighting aging

Advancing legislation and policies that aim to increase healthy human lifespan. Longevity is a journey that would be good to imagine we're all taking together;...

Team builds first living robots – that can reproduce

AI-designed Xenobots reveal entirely new form of biological self-replication which could prove promising for regenerative medicine. Birds do it, bees do it... now even living...

Aging in place trailblazer focus – Carewell

Carewell – aiding individuals through their caregiving journey with empathy and knowledge. Over the coming weeks, we will be bringing you extracts from 7 trailblazer...

Click the globe for translations.

On Deck Longevity Biotech Fellowship is on a mission to increase the number of people working to build longevity biotechnology companies.

The ODLB describes itself as “a continuous community for people to come together to build, join, or invest in revolutionary longevity biotechnology start-ups” – a longevity bootcamp where antiaging ideas can be workshopped and developed under the guidance of mentors (“Founding Fellows”).

Longevity.Technology: The longevity space is booming; just recently we launched our investment portal, featuring a carefully-curated set of opportunities and bringing innovators and investors together. Now, with the launch of this Fellowship, there is tuition and guidance available for those with the gleam of an idea that’s crying out for nurture.

Hosted on the established On Deck platform, the Longevity Biotech Fellowship aims to offer talented entrepreneurs, graduate students and academics guidance in building aging/regenerative medicine biotech start-ups by embedding them in a community of experts and mentors (experienced founders, pharma veterans, VCs and scientists).

The Fellowship programme includes seminars, talks, mastermind groups, networking events, mentor office hours, and pitch competition / demo days, with speakers such as David Sinclair, Laura Deming, Jim Mellon, George Church and Aubrey de Grey already lined up.

Rubedo
Marco Quarta CEO, Rubedo LIfe Sciences.

Founding Fellows who have agreed to provide advice and guidance include Marco Quarta of Rubedo Life Science, Kristen Fortney of BioAge Labs, Jean Hebert of the Albert Einstein College of Medicine, Matt Kaeberlein of the University of Washington, Morgan Levine of Yale, Sebastian Brunemeier of Apollo Health Ventures and Cambrian Biopharma, Reason of Repair Biotechnologies, Daniel Ives of Shift Bioscience, Anastasiya Giarletta of R42 Group, Sergio Ruiz of Turn Bio, Petr Sramek of Longevitytech.fund and Marc Bernegger of Maximon.

The Longevity Biotech Fellowship came about when Erik Torenberg, the co-founder of On Deck, decided a longevity fellowship was needed and reached out to Nathan Cheng, the man behind Longevity List, Longevity Marketcap and Biohack Stack.

Nathan Cheng
Nathan Cheng, Longevity List, Longevity Marketcap and Biohack Stack

Cheng, who is now ODLB’s Program Director and and Ada Nguyen, Program Partner, hope to address the fact that as more and more capital flows into the antiaging biotechnology sector, the major obstacle to progress has become the lack of founders.

“Many mission-driven individuals who want to get involved in longevity biotechnology don’t know how to get started, or feel like they don’t have the necessary background, network, or resources to have an impact,” says Cheng. “The Fellowship aims to change that.”

The programme costs $2990 per year or $1490 per year for academics, with a limited number of scholarships also available. The first cohort will kick off on 12th September later this year, and the fellowship aims to onboard three cohorts per year. Operating mostly online (for COVID and geographical reasons), there will also be some in-person events in San Francisco and Boston.

ODLB

Founding Fellow Daniel Ives of Shift Bioscience says of his role as mentor: “Leveraging their extended exposure to the Longevity field, mentors can help maximize signal-to-noise for founders, directing founders to the frontlines of science and drug development. Longevity is also a difficult and long-term mission – by setting expectations, mentors can help founders stay faithful to the mission and not fall prey to mission-second monopolists. Even in the fast-paced race for rejuvenation, experience still counts for something, and mentors can help steer founders away from the traps and dead ends they’ve previously encountered.”

Founding Fellow Marco Quarta of Rubedo Life Science said: “It is our responsibility to pass our experience to others and help them to succeed. Enabling and facilitating extraordinary people to join the mission of extending life span and health span can only be for everyone’s benefit.”

We look forward to seeing longevity dreams start their journey towards reality – perhaps when they become start-ups looking for investment, we’ll even see some featured on our portal!

Learn more about the Longevity Biotech Fellowship HERE and find out all about our investment portal HERE.

Images courtesy of Daniel Ives, Rubedo LIfe Science and Nathan Cheng
Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

Most popular

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Related articles

Printers that can now print DNA

DNA Script obtains CE Mark for SYNTAX DNA printing platform. DNA Script, a leader in Enzymatic DNA Synthesis (EDS), announced the CE marking of its SYNTAX System, the...

Eliminating senescent cells in fat can alleviate signs of diabetes

Deleting dysfunctional cells could lead to game-changing treatments for diabetes and other metabolic diseases. Eliminating old, dysfunctional cells in human fat also alleviates signs of...

Longevica: bridging the gap between longevity science and consumers

Longevica CEO sheds further light on work to develop an “open research platform” to drive both longevity science and commercialisation. Following yesterday’s $2.5 million funding...

Longevity Science Summit: care of aging population talks continue

Our dive into Longevity Week's Science Summit continues... Last week, Longevity.Technology was lucky enough to attend Longevity Forum's Science Summit at Oxford's Oriel College, part...

Young blood: discover the possibilities of plasma based therapy

The evolution of plasma-based therapeutics is accelerating – our FREE report cuts through the young blood hype for the lowdown on the latest therapies. Our...

    Subscribe to our newsletter